HAONasdaqServices-Advertising AgenciesFiscal year ends June 30

Haoxi Health Technology Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026

$2.06−0.05 (-2.37%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Haoxi Health Technology reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Haoxi Health Technology's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Haoxi Health Technology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2561 reverse split on Sep 30, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HAO.

Company	Revenue	Growth
HAO	$54.83M	+67.1%
INUV	$52.29M	-46.6%
TJGC	–	–
VSME	–	–
TNMG	–	–
STFS	–	–

Company

Exchange: Nasdaq
Industry: Services-Advertising Agencies
Fiscal year ends: June 30
Employees: 30
Auditor: HCL, PLLC
SEC CIK: 1954594

Advertisement
300 × 250